Glomerular Filtration Rate
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Trans-ethnic kidney function association study reveals putative causal genes and effects on kidney-specific disease aetiologies.
|
30604766 |
2019 |
Longevity
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
A meta-analysis of genome-wide association studies identifies multiple longevity genes.
|
31413261 |
2019 |
Cerebrovascular accident
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes.
|
29531354 |
2018 |
Ischemic stroke
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes.
|
29531354 |
2018 |
Cerebral Hemorrhage
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage.
|
24656865 |
2014 |
Cerebral Hemorrhage
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Meta-analysis of genome-wide association studies identifies 1q22 as a susceptibility locus for intracerebral hemorrhage.
|
24656865 |
2014 |
Malignant neoplasm of urinary bladder
|
0.020 |
PosttranslationalModification
|
disease |
BEFREE |
In a retrospective design, PMF-1 methylation was analyzed on tumor specimens belonging to 108 patients with T1HG NMI bladder cancer undergoing BCG treatment.
|
22682992 |
2013 |
Bladder Neoplasm
|
0.020 |
PosttranslationalModification
|
disease |
BEFREE |
In a retrospective design, PMF-1 methylation was analyzed on tumor specimens belonging to 108 patients with T1HG NMI bladder cancer undergoing BCG treatment.
|
22682992 |
2013 |
Carcinoma of bladder
|
0.020 |
PosttranslationalModification
|
disease |
BEFREE |
In a retrospective design, PMF-1 methylation was analyzed on tumor specimens belonging to 108 patients with T1HG NMI bladder cancer undergoing BCG treatment.
|
22682992 |
2013 |
Malignant neoplasm of urinary bladder
|
0.020 |
PosttranslationalModification
|
disease |
BEFREE |
After identifying an enriched CpG island encompassing the PMF1 promoter, we aimed at evaluating the clinical relevance of PMF1 methylation in bladder cancer.
|
19088041 |
2008 |
Bladder Neoplasm
|
0.020 |
PosttranslationalModification
|
disease |
LHGDN |
An initial set of 101 primary frozen bladder tumors served to identify PMF1 hypermethylation in 88.1% of the cases.
|
19088041 |
2008 |
Bladder Neoplasm
|
0.020 |
Biomarker
|
disease |
BEFREE |
An initial set of 101 primary frozen bladder tumors served to identify PMF1 hypermethylation in 88.1% of the cases.
|
19088041 |
2008 |
Carcinoma of bladder
|
0.020 |
PosttranslationalModification
|
disease |
BEFREE |
After identifying an enriched CpG island encompassing the PMF1 promoter, we aimed at evaluating the clinical relevance of PMF1 methylation in bladder cancer.
|
19088041 |
2008 |
Neoplasms
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Among the 108 patients analyzed, 35 had recurring disease (32.4%), 21 progressed (19.4%), and 16 died of disease (14.8%); 71.3% of tumors had PMF-1 methylation.
|
22682992 |
2013 |
Carcinoma of urinary bladder, invasive
|
0.010 |
Biomarker
|
disease |
BEFREE |
Indeed, several studies have revealed that methylated genes--including CDH1, FHIT, LAMC2, RASSF1A, TIMP3, SFRP1, SOX9, PMF1 and RUNX3--are associated with poor survival in patients with MIBC.
|
23628807 |
2013 |
Tumor Progression
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
The association of PMF1 methylation with tumor progression and its diagnostic ability using urinary specimens support including PMF1 assessment for the clinical management of bladder cancer patients.
|
19088041 |
2008 |